Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Chen, Xiaorong ^a,b   Yang, Zongguo ^a,b   Lu, Yunfei ^a,b   Xu, Qingnian ^a,b   Wang, Qiang ^a   Chen, Liang ^a  

^a SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

^b Key Lab of Infectious Diseases State Administration of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CEFOPERAZONE; CILASTATIN; CREATININE; GLUCOCORTICOID; HERBACEOUS AGENT; HOISTING POWDER; IMIPENEM; IMMUNOGLOBULIN; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; MYOGLOBIN; OSELTAMIVIR; PIPERACILLIN; QINGWEN BAIDU DECOCTION; SULBACTAM; UNCLASSIFIED DRUG; YINQIAO POWDER;

APPETITE DISORDER; ARTICLE; BACTERIAL INFECTION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD45+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; COUGHING; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; FATIGUE; FEMALE; FEVER; HEMOPTYSIS; HUMAN; INFECTION RISK; INFLUENZA A; INFLUENZA A (H7N9); INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N9; KIDNEY FAILURE; LABORATORY TEST; MALE; PATIENT; RECOVERED PATIENT; RISK FACTOR; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CREATININE; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MYOGLOBIN;

EID: 84884265728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073362     Document Type: Article

References (32)

1. Capua I, Alexander DJ, (2004) Avian influenza: recent developments. Avian Pathol 4: 393-404.
2. Gatherer D, (2009) The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 45: 174-178.
3. Guleria R, Kumar J, Mohan A, Wig N, (2012) Influenza A: From highly pathogenic H5N1 to pandemic 2009 H1N1. Epidemiology and clinical features. Indian J Microbiol 49: 315-319.
4. Swayen DE, Suarez DL, (2000) Highly pathogenic avian influenza. Rev Sci Tech 19: 463-482.
5. Xinhua News. Expert review: the clinical symptoms between the father and the son with H7N9 virus infection in Shandong province were obviously different, difficult to support the probability of human-to-human transmission of H7N9 virus. Available: http://news.xinhuanet.com/health/2013-04/29/c_115594440.htm.
6. Parry J, (2013) H7N9 avian flu kills seven and infects 23 in China. BMJ 346: f2222.
7. Parry J, (2013) H7N9 avian flu infects humans for the first time. BMJ 346: f2151.
8. Gao RB, Cao B, Hu YW, Feng ZJ, Wang DY, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Eng J Med doi: 10.1056/NEJMoa1304459.
9. National Health and Family Planning Commission of the People's Republic of China. Diagnosis and treatment program of humankind H7N9 avian influenza infection (the 2nd edition, 2013). Available: http://www.moh.gov.cn/mohyzs/s3585/201304/826ca1fb686f41ab9e8938ecdfa46a70.shtml.
10. Uyeki TM, Cox NJ (2013) Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections. N Eng J Med doi: 10.1056/NEJMp1304661.
11. Liu J, Manheimer E, Shi Y, Gluud C, (2004) Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med 6: 1041-51.
12. Lu CJ, Luo Y, Zhou H, Qin XL, Chen BJ, et al. (2010) A Preliminary Study on the Medical Expenditure of Chinese Medicine and Integrative Medicine Treatment for Influenza A (H1N1) in the Fever Clinics. Chin J Integr Med 6: 493-497.
13. The World Health Organization Influenza at human-animal interface, Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO. Available:http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html.
14. Guan Y, Farooqui A, Zhu HC, Dong W, Wang J, et al. (2013) H7N9 Incident, immune status, the elderly and a warning of an influenza pandemic. J Infect Dev Ctries 4: 302-307.
15. Alexander DJ, (2000) A review of avian influenza in different bird species. Vet Microbiol 74: 3-13.
16. The Beijing News. 40 percent of avian influenza had no contact with poultry. Available: http://epaper.bjnews.com.cn/html/2013-04/17/content_427238.htm?div=-1.
17. Li Q, Zhou L, Zhou MH, Chen ZP, Li FR, et al. (2013) Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. N Eng J Med doi: 10.1056/NEJMoa1304617.
18. Zimmerman O, Rogowski O, Aviram G, Mizrahi M, Zeltser D, et al. (2010) C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis 10: 288.
19. Haran JP, Suner S, Gardiner F, (2012) Correlation of C-reactive protein to severity of symptoms in acute influenza A infection. J Emerg Trauma Shock 2: 149-52.
20. Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL, (2008) CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 7: 4918-4925.
21. Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL, (2000) Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 11-12: 1088-1095.
22. Reemers SS, van Haarlem DA, Sijts AJ, Vervelde L, Jansen CA, (2012) Identification of novel avian influenza virus derived CD8+ T-cell epitopes. Plos One 2: e31953.
23. Brown DM, Roman E, Swain SL, (2004) CD4 T cell responses to influenza infection. Semin Immunol 3: 171-177.
24. Swain SL, Agrewala JN, Brown DM, Jelley-Gibbs DM, Golech S, et al. (2006) CD4 + T-cell memory: Generation and multi-faceted roles for CD4 + T cells in protective immunity to influenza. Immunol Rev 211: 8-22.
25. Hermiston ML, Xu Z, Weiss A, (2003) CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21: 107-37.
26. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ, (2001) CD45: new jobs for an old acquaintance. Nat Immunol 5: 389-96.
27. Byth KF, Conroy LA, Howlett S, Smith AJ, May J, et al. (1996) CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp Med 4: 1707-18.
28. Kung C, Pingel JT, Heikinheimo M, Klemola T, Varkila K, et al. (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 3: 343-5.
29. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, et al. (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2: 1308-13.
30. Han K, Ma H, An X, Su Y, Chen J, et al. (2011) Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis 4: 326-33.
31. He Z, Wu G, Chen P, Ouyang R, Li J, (2010) Clinical analysis of critically ill patients with H1N1 influenza. Zhong Nan Da Xue Xue Bao Yi Xue Ban 7: 655-61.
32. Carter MJ, (2007) A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol Pt 7: 875-83.